GAM Systematic’s Usana Health Sciences USNA Stock Holding History

GAM Systematic’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$995K	Sell	17,241 -10,294	-37%	-$608K	0.14%	285
2017 Q2	$1.76M	Buy	27,535 +19,969	+264%	+$1.23M	0.25%	137
2017 Q1	$436K	Sell	7,566 -8,092	-52%	-$483K	0.09%	391
2016 Q4	$958K	Buy	15,658 +1,880	+14%	+$122K	0.23%	168
2016 Q3	$953K	Buy	13,778 +5,686	+70%	+$375K	0.2%	200
2016 Q2	$451K	Buy	8,092 +2,276	+39%	+$137K	0.11%	357
2016 Q1	$353K	Sell	5,816 -11,660	-67%	-$686K	0.09%	377
2015 Q4	$1.12M	Buy	17,476 +6,256	+56%	+$406K	0.32%	73
2015 Q3	$752K	Buy	+11,220	New	+$793K	0.17%	248

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Systematic's USNA Position: Q3 2017 in Review

GAM Systematic reduced its Usana Health Sciences (USNA) stake by 37% in Q3 2017, selling an estimated $608K and leaving 17,241 shares worth $995K. The position accounts for 0.14% of the portfolio, ranked #285.

GAM Systematic first reported a position in USNA in Q3 2015 and has held it in 9 quarters since. The position peaked at $1.76M in Q2 2017. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

GAM Systematic held 17,241 shares of Usana Health Sciences worth $995K as of Q3 2017.
GAM Systematic sold 10,294 Usana Health Sciences shares in Q3 2017, an estimated $608K.
Usana Health Sciences made up 0.14% of GAM Systematic's portfolio in Q3 2017, its #285 holding.
GAM Systematic first reported a position in Usana Health Sciences in Q3 2015 and has held it in 9 quarters since.
GAM Systematic's Usana Health Sciences position peaked at $1.76M in Q2 2017.
144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.